---
company: Teladoc Health, Inc.
ticker: TDOC
form: 8-K
filed: 2026-07-29
accession: 0001477449-26-000036
source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000036/
---

# Teladoc Health (TDOC) earnings release, July 29, 2026

Teladoc Health, Inc. (TDOC) · Form 8-K, Item 2.02 · Filed 2026-07-29 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1477449/000147744926000036/)

Teladoc Health Reports Second Quarter 2026 Results

NEW YORK, July 29, 2026 — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 (“Second Quarter 2026”). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2025 (“Second Quarter 2025”).

Highlights

• Second Quarter 2026 revenue of $606.9 million, down 4% year-over-year

• Second Quarter 2026 net loss of $38.9 million, or $0.21 per share

• Second Quarter 2026 adjusted EBITDA of $65.7 million, down 5% year-over-year

• Integrated Care segment revenue of $394.3 million, up 1% year-over-year, and adjusted EBITDA margin of 16.5%

• BetterHelp segment revenue of $212.6 million, down 12% year-over-year, and adjusted EBITDA margin of 0.2%

“We continue to make progress on the priorities we believe are most important to the long-term success of Teladoc Health. Our second-quarter results were within our guidance ranges on a consolidated basis and reflected distinct dynamics across our two segments,” said Chuck Divita, Chief Executive Officer of Teladoc Health. “We delivered solid Integrated Care segment performance, with revenue growth and adjusted EBITDA margin above the midpoint of our guidance ranges and continued to advance new innovations designed to strengthen the value we provide to clients and members, including the launch of Teladoc One, our new connected care model for the U.S. market.”

“In the BetterHelp segment, insurance revenue came in near the high end of our expectations. However, pressure on cash pay revenue accelerated further in late May and into June, beyond the assumptions underlying our prior outlook. We saw stronger than anticipated demand for insurance covered services that outpaced available provider capacity, limiting our ability to convert a greater share of that demand into sessions and revenue to offset the cash pay decline. Given strong consumer preference for insurance, we accelerated the nationwide insurance rollout ahead of plan, and we are taking focused actions to further support the scaling of insurance.

We continue to expect 2026 insurance revenue within our previously communicated range, but we have lowered our BetterHelp segment revenue outlook to reflect updated assumptions for cash pay including prioritization of the growing insurance market. We are addressing BetterHelp’s near-term challenges with urgency and discipline and believe these actions will strengthen our ability to meet growing insurance demand and position the segment for more durable performance over time.”

See note (1) in the Notes section that follows.¹

Second Quarter 2026

Revenue decreased 4% to $606.9 million from $631.9 million in Second Quarter 2025. Access fees revenue decreased 9% to $474.2 million while other revenue increased 23% to $132.7 million. U.S. revenue decreased 6% to $487.4 million while International revenue increased 7% to $119.6 million.

Integrated Care segment revenue increased 1% to $394.3 million in Second Quarter 2026 while BetterHelp segment revenue decreased 12% to $212.6 million.

Net loss totaled $38.9 million, or $0.21 per share, for Second Quarter 2026, compared to $32.7 million, or $0.19 per share, for Second Quarter 2025. Results for Second Quarter 2026 included amortization of intangibles of $88.4 million, or $0.49 per share pre-tax, and stock-based compensation expense of $9.3 million, or $0.05 per share pre-tax.

Results for Second Quarter 2025 included amortization of intangibles of $88.7 million, or $0.50 per share pre-tax, and stock-based compensation expense of $22.3 million or $0.13 per share pre-tax. Net loss for Second Quarter 2025 also included restructuring costs related to severance costs and costs associated with office space reductions of $5.7 million, or $0.03 per share pre-tax. These items were partially offset by an acquisition related tax benefit of $9.7 million, or $0.06 per share.

Adjusted EBITDA

(1) decreased 5% to $65.7 million, compared to $69.3 million for Second Quarter 2025. The Integrated Care segment adjusted EBITDA increase of $7.8 million was offset by a $11.4 million decrease of the BetterHelp segment adjusted EBITDA in Second Quarter 2026.

Six Months Ended June 30, 2026

Revenue decreased 3% to $1,220.8 million from $1,261.3 million in the first six months of 2025. Access fees revenue decreased 9% to $958.9 million while other revenue increased 24% to $261.9 million. U.S. revenue decreased 6% to $978.9 million while International revenue increased 12% to $241.9 million.

Integrated Care segment revenue increased 1% to $789.8 million in the first six months of 2026 while BetterHelp segment revenue decreased 10% to $431.0 million.

Net loss totaled $102.7 million, or $0.57 per share, for the first six months of 2026, compared to $125.7 million, or $0.72 per share, for the first six months of 2025. Results for the first six months of 2026 included amortization of intangibles of $178.3 million, or $0.99 per share pre-tax, and stock-based compensation expense of $23.9 million, or $0.13 per share pre-tax. Net loss for the first six months of 2026 also included restructuring costs of $12.9 million, or $0.07 per share pre-tax, primarily related to severance costs.... (truncated)it study and acquisition related tax benefits of $11.1 million, or $0.06 per share.

The non-cash goodwill impairment charge recorded in the first six months of 2025 was the result of the fair value of the Integrated Care segment being less than its carrying value at the time of the acquisition of Catapult Health, LLC.

Adjusted EBITDA

(1) decreased 3% to $123.9 million, compared to $127.4 million for the first six months of 2025. The Integrated Care segment adjusted EBITDA increase of $13.7 million was offset by a $17.2 million decrease of the BetterHelp segment adjusted EBITDA in the first six months of 2026.

Capex and Cash Flow

Cash flow from operations was $64.7 million in Second Quarter 2026, compared to $91.4 million in Second Quarter 2025, and was $74.2 million in the first six months of 2026, compared to $107.4 million in the first six months of 2025. Capital expenditures and capitalized software development costs (together, “Capex”)² were $28.9 million in Second Quarter 2026, compared to $30.2 million in Second Quarter 2025, and were $64.7 million in the first six months of 2026, compared to $61.8 million in the first six months of 2025. Free cash flow was $35.7 million in Second Quarter 2026, compared to $61.2 million in Second Quarter 2025, and was $9.4 million in the first six months of 2026, compared to $45.5 million in the first six months of 2025.

Financial Outlook

The outlook provided below is based on current market conditions and expectations and what we know today.

See note (2) in the Notes section that follows.³

Earnings Conference Call

The Second Quarter 2026 earnings conference call and webcast will be held Wednesday, July 29, 2026 at 5:00 p.m. E.T. The conference call can be accessed by dialing 833-461-5787 for U.S. participants and using the conference ID # 478 236 923. For international participants, please visit the following link for global dial-in numbers, using the same conference ID # 478 236 923: https://help.events.q4inc.com/eahc/international-dial-in-numbers. A live audio webcast will also be available online at http://ir.teladoc.com/news-and-events/events-and-presentations/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Teladoc Health

Teladoc Health is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at www.teladochealth.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, the information under the caption “Financial Outlook” and statements we make regarding future financial or operating results, future numbers of members, BetterHelp paying users or clients, litigation outcomes, regulatory developments, market developments, new products and growth strategies, initiatives to improve our efficiency and competitiveness, and the effects of any of the foregoing on our future results of operations or financial condition.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that have in the past and/or may in the future cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) changes in laws and regulations applicable to our business model; (ii) changes in market conditions and receptivity to our services and offerings, including our ability to effectively compete; (iii) results of litigation or regulatory actions; (iv) the loss of one or more key clients or the loss of a significant number of members or BetterHelp paying users; (v) a decrease in revenue from users who pay directly out-of-pocket without offsetting growth in insurance-covered services in our BetterHelp segment; (vi) changes in valuations or useful lives of our assets; (vii) changes to our abilities to recruit and retain qualified providers into our network; (viii) the impact of and risk related to impairment losses with respect to goodwill or other assets; (ix) the success of our initiatives to improve our efficiency and competitiveness; (x) imposed and threatened tariffs by the United States and its trading partners, and any resulting disruptions or inefficiencies in our supply chain; (xi) the rate and magnitude of declines in BetterHelp cash-pay users and revenue; (xii) the extent to which insurance availability changes users’ payment choices; (xiii) available provider capacity including on a state and payer specific basis; (xiv) the timing, cost and effectiveness of provider recruitment, credentialing, enrollment, activation, compensation and retention; (xv) the performance of insurance-specific eligibility, matching, booking, scheduling, utilization, session-duration, claims and collection workflows; (xvi) the effectiveness and revenue consequences of changes in advertising and marketing spending; (xvii) the effects of BetterHelp’s reduced near term emphasis and investment outside the United States; (xviii) the cost, timing and effectiveness of platform and provider-capacity investments; (xix) the margin effects of the insurance mix; and (xx) potential impairment of BetterHelp goodwill. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our SEC reports, including, but not limited to, our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the SEC.⁴

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required by law.⁵

## Financial statements

### Income Statement (In thousands, except per share data, unaudited)

| | Three Months Ended – June 30, – 2026 | Three Months Ended – June 30, – 2025 | Change | Six Months Ended – June 30, – 2026 | Six Months Ended – June 30, – 2025 | Change |
|---|---:|---:|---:|---:|---:|---:|
| (In thousands, except per share data, unaudited) | Revenue | 606,927 | 631,900 | -4.0% | 1,220,772 | 1,261,269 | -3 |
| (In thousands, except per share data, unaudited) | Net loss | -38,908 | -32,660 | -19.0% | -102,745 | -125,672 | 18 |
| (In thousands, except per share data, unaudited) | Net loss per share | -0.21 | -0.19 | -11.0% | -0.57 | -0.72 | 21 |
| (In thousands, except per share data, unaudited) | Adjusted EBITDA (1) | 65,713 | 69,311 | -5.0% | 123,882 | 127,404 | -3 |

### Income Statement (The outlook provided below is based on current market conditions and expectations and what we know today.)

| | Full Year 2026 Outlook Range |
|---|---:|
| For the full year of 2026, we expect: | Revenue | $2,362 - $2,447 million |
| For the full year of 2026, we expect: | Adjusted EBITDA | $271 - $303 million |
| For the full year of 2026, we expect: | Net loss per share | ($1.00) - ($0.75) |
| For the full year of 2026, we expect: | Free Cash Flow | $130 - $170 million |
| For the full year of 2026, we expect: | U.S. Integrated Care Members (2) | 98.5 - 100.5 million |
| Integrated Care | Revenue growth percentage (year-over-year) | 0.8% - 2.4% |
| Integrated Care | Adjusted EBITDA margin | 15.6% - 16.4% |
| BetterHelp | Revenue growth percentage (year-over-year) | (19.0%) - (12.7%) |
| BetterHelp | Adjusted EBITDA margin | 3.0% - 4.6% |

### Income Statement (For the third quarter of 2026, we expect: — The outlook provided below is based on current market conditions and expectations and what we know today.)

| | For the third quarter of 2026, we expect: – 3Q 2026 Outlook Range |
|---|---:|
| Revenue | $569 - $609 million |
| Adjusted EBITDA | $62 - $74 million |
| Net loss per share | ($0.30) - ($0.20) |
| U.S. Integrated Care Members (2) | 99.0 - 100.5 million |
| Integrated Care | Revenue growth percentage (year-over-year) | 0.0% - 3.0% |
| Integrated Care | Adjusted EBITDA margin | 15.7% - 17.2% |
| BetterHelp | Revenue growth percentage (year-over-year) | (24.2%) - (12.3%) |
| BetterHelp | Adjusted EBITDA margin | 0.5% - 2.5% |

### Income Statement (Three Months Ended June 30, — (In thousands, except share and per share data, unaudited))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Revenue | 606,927 | 631,900 | 1,220,772 | 1,261,269 |
| Costs and expenses: | Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) | 190,837 | 190,537 | 388,363 | 387,366 |
| Costs and expenses: | Advertising and marketing | 143,397 | 167,547 | 294,924 | 335,732 |
| Costs and expenses: | Sales | 49,391 | 49,951 | 100,667 | 98,644 |
| Costs and expenses: | Technology and development | 62,861 | 68,784 | 130,726 | 138,742 |
| Costs and expenses: | General and administrative | 104,029 | 108,114 | 206,122 | 220,888 |
| Costs and expenses: | Goodwill impairment |  |  |  | 59,138 |
| Costs and expenses: | Acquisition, integration, and transformation costs | 1,690 | 2,658 | 2,754 | 4,846 |
| Costs and expenses: | Restructuring costs | 904 | 5,692 | 12,879 | 10,039 |
| Costs and expenses: | Amortization of intangible assets | 88,442 | 88,664 | 178,268 | 172,968 |
| Costs and expenses: | Depreciation of property and equipment | 2,468 | 4,338 | 4,929 | 7,902 |
| Costs and expenses: | Total costs and expenses | 644,019 | 686,285 | 1,319,632 | 1,436,265 |
| Costs and expenses: | Loss from operations | -37,092 | -54,385 | -98,860 | -174,996 |
| Costs and expenses: | Interest income | -6,481 | -10,064 | -12,971 | -22,738 |
| Costs and expenses: | Interest expense | 5,109 | 4,473 | 10,477 | 10,238 |
| Costs and expenses: | Other expense (income), net | 2,191 | -8,371 | 2,387 | -10,806 |
| Costs and expenses: | Loss before provision for income taxes | -37,911 | -40,423 | -98,753 | -151,690 |
| Costs and expenses: | Provision for income taxes | 997 | -7,763 | 3,992 | -26,018 |
| Costs and expenses: | Net loss | -38,908 | -32,660 | -102,745 | -125,672 |
| Costs and expenses: | Net loss per share, basic and diluted | -0.21 | -0.19 | -0.57 | -0.72 |
| Costs and expenses: | Weighted-average shares used to compute basic and diluted net loss per share | 181,026,004 | 175,917,380 | 180,079,395 | 175,040,625 |

### Income Statement (Three Months Ended June 30, — Compensation expense for stock-based awards was classified as follows (in thousands, unaudited):)

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Cost of revenue (exclusive of depreciation and amortization, which are shown separately) | 124 | 506 | 471 | 1,079 |
| Advertising and marketing | 426 | 1,302 | 1,286 | 2,805 |
| Sales | 1,460 | 3,594 | 3,537 | 7,853 |
| Technology and development | 1,735 | 4,247 | 4,462 | 10,032 |
| General and administrative | 5,556 | 12,695 | 14,156 | 25,738 |
| Total stock-based compensation expense (3) | 9,301 | 22,344 | 23,912 | 47,507 |

### Income Statement (Three Months Ended — Revenues (in thousands))

| | Three Months Ended – June 30, – 2026 | Three Months Ended – June 30, – 2025 | Change | Six Months Ended – June 30, – 2026 | Six Months Ended – June 30, – 2025 | Change |
|---|---:|---:|---:|---:|---:|---:|
| Access Fees | 474,215 | 523,703 | -9 | 958,870 | 1,049,439 | -9 |
| Other | 132,712 | 108,197 | 23 | 261,902 | 211,830 | 24 |
| Total Revenue | 606,927 | 631,900 | -4 | 1,220,772 | 1,261,269 | -3 |
| Revenue by Geography | U.S. | 487,360 | 519,689 | -6 | 978,865 | 1,044,659 | -6 |
| Revenue by Geography | International | 119,567 | 112,211 | 7 | 241,907 | 216,610 | 12 |
| Revenue by Geography | Total Revenue | 606,927 | 631,900 | -4 | 1,220,772 | 1,261,269 | -3 |

### Income Statement ((In thousands, unaudited) (in thousands))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | Outlook in millions (8) – Second Quarter – 2026 | Outlook in millions (8) – Full Year – 2026 |
|---|---:|---:|---:|---:|---:|---:|
| Net loss | -38,908 | -32,660 | -102,745 | -125,672 | $(55) - (36) | $(181) - (136) |
| Add: | Provision for income taxes | 997 | -7,763 | 3,992 | -26,018 |  |  |
| Add: | Other expense (income), net | 2,191 | -8,371 | 2,387 | -10,806 |  |  |
| Add: | Interest expense | 5,109 | 4,473 | 10,477 | 10,238 |  |  |
| Add: | Interest income | -6,481 | -10,064 | -12,971 | -22,738 |  |  |
| Add: | Depreciation of property and equipment | 2,468 | 4,338 | 4,929 | 7,902 |  |  |
| Add: | Amortization of intangible assets | 88,442 | 88,664 | 178,268 | 172,968 |  |  |
| Add: | Restructuring costs | 904 | 5,692 | 12,879 | 10,039 |  |  |
| Add: | Acquisition, integration, and transformation costs | 1,690 | 2,658 | 2,754 | 4,846 |  |  |
| Add: | Goodwill impairment |  |  |  | 59,138 |  |  |
| Add: | Stock-based compensation | 9,301 | 22,344 | 23,912 | 47,507 |  |  |
| Add: | Total Adjustments | 104,621 | 101,971 | 226,627 | 253,076 | 98 - 129 | 407 - 484 |
| Add: | Consolidated Adjusted EBITDA | 65,713 | 69,311 | 123,882 | 127,404 | $62 - 74 | $271 - 303 |
| Segment Adjusted EBITDA | Integrated Care | 65,242 | 57,450 | 121,519 | 107,829 |  |  |
| Segment Adjusted EBITDA | BetterHelp | 471 | 11,861 | 2,363 | 19,575 |  |  |
| Segment Adjusted EBITDA | Consolidated Adjusted EBITDA | 65,713 | 69,311 | 123,882 | 127,404 |  |  |

### Balance Sheet ((In thousands, except share and per share data, unaudited))

| | June 30, 2026 | December 31, 2025 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 774,348 | 781,084 |
| Current assets: | Accounts receivable, net of allowance for doubtful accounts of $3,628 and $4,033 at June 30, 2026 and December 31, 2025, respectively | 221,015 | 192,826 |
| Current assets: | Inventories | 28,823 | 38,203 |
| Current assets: | Prepaid expenses and other current assets | 124,175 | 107,016 |
| Current assets: | Total current assets | 1,148,361 | 1,119,129 |
| Current assets: | Property and equipment, net | 24,690 | 26,972 |
| Current assets: | Goodwill | 283,190 | 283,190 |
| Current assets: | Intangible assets, net | 1,175,669 | 1,297,087 |
| Current assets: | Operating lease—right-of-use assets | 22,718 | 26,119 |
| Current assets: | Other assets | 103,997 | 105,803 |
| Current assets: | Total assets | 2,758,625 | 2,858,300 |
| Current liabilities: | Accounts payable | 37,496 | 47,967 |
| Current liabilities: | Accrued expenses and other current liabilities | 226,550 | 198,208 |
| Current liabilities: | Accrued compensation | 60,172 | 96,258 |
| Current liabilities: | Deferred revenue, current | 60,812 | 62,305 |
| Current liabilities: | Convertible senior notes, net—current | 996,700 |  |
| Current liabilities: | Total current liabilities | 1,381,730 | 404,738 |
| Current liabilities: | Operating lease liabilities, net of current portion | 29,537 | 34,204 |
| Current liabilities: | Deferred revenue, net of current portion | 9,669 | 9,139 |
| Current liabilities: | Deferred taxes, net | 26,881 | 28,945 |
| Current liabilities: | Convertible senior notes, net—non-current |  | 994,925 |
| Current liabilities: | Other liabilities | 700 | 643 |
| Current liabilities: | Total liabilities | 1,448,517 | 1,472,594 |
| Stockholders’ equity: | Common stock, $0.001 par value; 300,000,000 shares authorized; 181,649,591 shares and 178,315,400 shares issued and outstanding as of June 30, 2026 and December 31, 2025 respectively | 182 | 178 |
| Stockholders’ equity: | Additional paid-in capital | 17,876,827 | 17,850,478 |
| Stockholders’ equity: | Accumulated deficit | -16,532,967 | -16,430,222 |
| Stockholders’ equity: | Accumulated other comprehensive loss | -33,934 | -34,728 |
| Stockholders’ equity: | Total stockholders’ equity | 1,310,108 | 1,385,706 |
| Stockholders’ equity: | Total liabilities and stockholders’ equity | 2,758,625 | 2,858,300 |

### Cash Flow (Six Months Ended June 30, — (In thousands, unaudited) (in thousands))

| | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|
| Cash flows from operating activities: | Net loss | -102,745 | -125,672 |
| Adjustments to reconcile net loss to net cash flows from operating activities: | Goodwill impairment |  | 59,138 |
| Adjustments to reconcile net loss to net cash flows from operating activities: | Amortization of intangible assets | 178,268 | 172,968 |
| Adjustments to reconcile net loss to net cash flows from operating activities: | Stock-based compensation | 23,912 | 47,507 |
| Adjustments to reconcile net loss to net cash flows from operating activities: | Depreciation of property and equipment | 4,929 | 7,902 |
| Adjustments to reconcile net loss to net cash flows from operating activities: | Amortization of right-of-use assets | 3,394 | 4,190 |
| Adjustments to reconcile net loss to net cash flows from operating activities: | Provision for allowances for doubtful accounts | 807 | 377 |
| Adjustments to reconcile net loss to net cash flows from operating activities: | Deferred income taxes | -1,673 | -34,072 |

### Cash Flow (Three Months Ended — (In thousands, unaudited) (in millions))

| | Three Months Ended – June 30, – 2026 | Three Months Ended – June 30, – 2025 | Six Months Ended – June 30, – 2026 | Six Months Ended – June 30, – 2025 | Outlook (9) – Full Year |
|---|---:|---:|---:|---:|---:|
| Net cash provided by operating activities | 64,662 | 91,432 | 74,178 | 107,351 | $260 - 290 |
| Capital expenditures | -928 | -1,268 | -2,588 | -3,994 |  |
| Capitalized software development costs | -27,990 | -28,965 | -62,152 | -57,824 |  |
| Capex | -28,918 | -30,233 | -64,740 | -61,818 | (130) - (120) |
| Free Cash Flow | 35,744 | 61,199 | 9,438 | 45,533 | $130 - 170 |
